标普和纳斯达克内在价值 联系我们

Lite Strategy, Inc. LITS NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
50/100
1/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Lite Strategy, Inc. (LITS) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.

分析师预估 每股收益(EPS)为 $3.62 和 营收为 $0.07B (下一财年).

每股收益(EPS)历史表现: 2024: 实际 $2.67 vs 预期 $3.62 (不及预期 -26.2%). 2025: 实际 $-2.39 vs 预期 $-6.28 (超预期 +61.9%). 分析师准确度: 1%.

EPS 预测 — LITS

1%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual $2.67 vs Est $3.62 ▼ 35.6% off
2025 Actual –$2.39 vs Est –$6.28 ▲ 162.8% off
Profitability Outlook
Company has mixed profitability — some years profitable, some at a loss. Analysts expect the company to turn profitable.

营收预测 — LITS

100%
Analyst Accuracy
Accurate
1 year compared
Actual vs Estimate
2024 Actual $0.065B vs Est $0.065B ▼ 0.0% off
Revenue Trend
Revenue has declined over the period shown. Analysts expect stable revenue going forward.
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言